Vantage Investment Advisors’s Hologic HOLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-400
Closed -$18K 809
2017
Q2
$18K Hold
400
0.01% 440
2017
Q1
$17K Hold
400
0.01% 426
2016
Q4
$16K Hold
400
0.01% 437
2016
Q3
$16K Sell
400
-312
-44% -$11.8K 0.01% 420
2016
Q2
$25K Hold
712
0.01% 380
2016
Q1
$25K Buy
712
+100
+16% +$3.49K 0.01% 359
2015
Q4
$24K Buy
612
+300
+96% +$11.7K 0.01% 349
2015
Q3
$12K Hold
312
0.01% 461
2015
Q2
$12K Hold
312
0.01% 448
2015
Q1
$10K Hold
312
﹤0.01% 603
2014
Q4
$8K Hold
312
﹤0.01% 543
2014
Q3
$8K Hold
312
﹤0.01% 500
2014
Q2
$8K Hold
312
﹤0.01% 505
2014
Q1
$7K Hold
312
﹤0.01% 482
2013
Q4
$7K Buy
+312
New +$6.88K ﹤0.01% 451

Other funds holding HOLX

Vantage Investment Advisors's HOLX Position: Q3 2017 in Review

Vantage Investment Advisors sold out of Hologic (HOLX) in Q3 2017, closing a stake of 400 shares — an estimated $18K sold.

Vantage Investment Advisors first reported a position in HOLX in Q4 2013 and held it in 15 quarters. The position peaked at $25K in Q2 2016. 457 funds tracked by Wall St. Rank hold HOLX as of Q3 2017.

  • Vantage Investment Advisors reported no remaining Hologic position as of Q3 2017 after selling out during the quarter.
  • Vantage Investment Advisors sold 400 Hologic shares in Q3 2017, an estimated $18K.
  • Vantage Investment Advisors first reported a position in Hologic in Q4 2013 and held it in 15 quarters.
  • Vantage Investment Advisors's Hologic position peaked at $25K in Q2 2016.
  • 457 funds tracked by Wall St. Rank held Hologic as of Q3 2017.

Based on Vantage Investment Advisors's 13F filing for Q3 2017, filed 13 Nov 2017.